Bone morphogenetic proteins in total hip arthroplasty, osteonecrosis and trauma surgery

References

• Urist MR. Bone: formation by autoinduction. 1965. Clin. Orthop. Relat. Res.395, 4–10 (2002).
   Google Scholar
• Reddi AH, Huggins CB. Influence of geometry of transplanted tooth and bone on transformation of fibroblasts. Proc. Soc. Exp. Biol. Med.143(3), 634–637 (1973).
   PubMedGoogle Scholar
• Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl Acad. Sci. USA78(12), 7599–7603 (1981).
   PubMed Web of Science ®Google Scholar
• Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Joint Surg.89(4), 780–785 (2007).
   PubMed Web of Science ®Google Scholar
• Mont MA, Ragland PS, Biggins B et al. Use of bone morphogenetic proteins for musculoskeletal applications. An overview. J. Bone Joint Surg.86A(Suppl. 2), 41–55 (2004).
   Google Scholar
• Brady OH, Garbuz DS, Masri BA, Duncan CP. The treatment of periprosthetic fractures of the femur using cortical onlay allograft struts. Orthop. Clin. North Am.30(2), 249–257 (1999).
   PubMedGoogle Scholar
• Emerson RH Jr, Malinin TI, Cuellar AD, Head WC, Peters PC. Cortical strut allografts in the reconstruction of the femur in revision total hip arthroplasty. A basic science and clinical study. Clin. Orthop. Relat. Res.285, 35–44 (1992).
   Google Scholar
• Head WC, Malinin TI, Mallory TH, Emerson RH, Jr. Onlay cortical allografting for the femur. Orthop. Clin. North Am.29(2), 307–312 (1998).
   PubMedGoogle Scholar
• Etienne G, Ragland PS, Mont MA. Use of cancellous bone chips and demineralized bone matrix in the treatment of acetabular osteolysis: preliminary 2-year follow-up. Orthopedics27(1 Suppl.), S123–S126 (2004).
   PubMed Web of Science ®Google Scholar
• Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications. J. Am. Acad. Orthop. Surg.3(1), 1–8 (1995).
   PubMedGoogle Scholar
• Pelker RR, Friedlaender GE, Markham TC. Biomechanical properties of bone allografts. Clin. Orthop. Relat. Res.174, 54–57 (1983).
   PubMed Web of Science ®Google Scholar
• Schwarz N, Schlag G, Thurnher M et al. Fresh autogeneic, frozen allogeneic, and decalcified allogeneic bone grafts in dogs. J. Bone Joint Surg. Br.73(5), 787–790 (1991).
   PubMedGoogle Scholar
• Hooten JP, Jr., Engh CA, Heekin RD, Vinh TN. Structural bulk allografts in acetabular reconstruction. Analysis of two grafts retrieved at post-mortem. J. Bone Joint Surg. Br.78(2), 270–275 (1996).
   PubMedGoogle Scholar
• Burchardt H. The biology of bone graft repair. Clin. Orthop. Relat. Res.174, 28–42 (1983).
   PubMed Web of Science ®Google Scholar
• Enneking WF, Burchardt H, Puhl JJ, Piotrowski G. Physical and biological aspects of repair in dog cortical-bone transplants. J. Bone Joint Surg.57(2), 237–252 (1975).
   PubMed Web of Science ®Google Scholar
• Celeste AJ, Iannazzi JA, Taylor RC et al. Identification of transforming growth factor b family members present in bone-inductive protein purified from bovine bone. Proc. Natl Acad. Sci. USA87(24), 9843–9847 (1990).
   PubMed Web of Science ®Google Scholar
• Jensen TB, Overgaard S, Lind M et al. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop. Scand.73(1), 31–39 (2002).
   PubMed Web of Science ®Google Scholar
• Lind M, Overgaard S, Jensen TB et al. Effect of osteogenic protein 1/collagen composite combined with impacted allograft around hydroxyapatite-coated titanium alloy implants is moderate. J. Biomed. Mater. Res.55(1), 89–95 (2001).
   PubMedGoogle Scholar
• Lind M, Overgaard S, Song Y et al. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J. Arthroplasty15(3), 339–346 (2000).
   PubMedGoogle Scholar
• Soballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bunger C. Bone graft incorporation around titanium-alloy- and hydroxyapatite-coated implants in dogs. Clin. Orthop. Relat. Res.274, 282–293 (1992).
   Google Scholar
• Greis PE, Kang JD, Silvaggio V, Rubash HE. A long-term study on defect filling and bone ingrowth using a canine fiber metal total hip model. Clin. Orthop. Relat. Res.274, 47–59 (1992).
   Google Scholar
• Karrholm J, Hourigan P, Timperley J, Razaznejad R. Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases. Acta Orthop.77(1), 39–48 (2006).
   PubMed Web of Science ®Google Scholar
• Cook SD, Barrack RL, Patron LP, Salkeld SL. Osteoinductive agents in reconstructive hip surgery: a look forward. Clin. Orthop. Relat. Res.417, 195–202 (2003).
   Google Scholar
• Bragdon CR, Doherty AM, Rubash HE et al. The efficacy of BMP-2 to induce bone ingrowth in a total hip replacement model. Clin. Orthop. Relat. Res.417, 50–61 (2003).
   Google Scholar
• Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J. Bone Joint Surg.77(3), 459–474 (1995).
   PubMed Web of Science ®Google Scholar
• Mont MA, Jones LC, Einhorn TA, Hungerford DS, Reddi AH. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin. Orthop. Relat. Res.355(Suppl.), S314–S335 (1998).
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Berry DJ, Mont MA et al. Osteonecrosis of the hip: management in the 21st Century. Instr. Course Lect.52, 337–355 (2003).
   PubMedGoogle Scholar
• Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin. Orthop. Relat. Res.429, 139–145 (2004).
   PubMed Web of Science ®Google Scholar
• Mont MA, Jones LC, Elias JJ et al. Strut-autografting with and without osteogenic protein-1 : a preliminary study of a canine femoral head defect model. J. Bone Joint Surg.83A(7), 1013–1022 (2001).
   Google Scholar
• Seyler TM, Marker DR, Ulrich SD, Fatscher T, Mont MA. Results of non-vascularized trapdoor bone grafting for femoral head osteonecrosis. Clin. Orthop. Relat. Res.(2007).
   Google Scholar
• Johnson EE, Urist MR, Finerman GA. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin. Orthop. Relat. Res.230, 257–265 (1988).
   PubMed Web of Science ®Google Scholar
• Johnson EE, Urist MR. One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein. Clin. Orthop. Relat. Res.347, 105–116 (1998).
   PubMedGoogle Scholar
• Johnson EE, Urist MR. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin. Orthop. Relat. Res.371, 61–74 (2000).
   Google Scholar
• Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin. Orthop. Relat. Res.277, 229–237 (1992).
   PubMedGoogle Scholar
• Johnson EE, Urist MR, Finerman GA. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin. Orthop. Relat. Res.250, 234–240 (1990).
   Google Scholar
• Friedlaender GE, Perry CR, Cole JD et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg.83A(Suppl. 1, Pt 2), S151–S158 (2001).
   Web of Science ®Google Scholar
• Govender S, Csimma C, Genant HK et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg.84A(12), 2123–2134 (2002).
   Web of Science ®Google Scholar
• Bilic R, Simic P, Jelic M et al. Osteogenic protein-1 (BMP-7) accelerates healing of scaphoid non-union with proximal pole sclerosis. Int. Orthop.30(2), 128–134 (2006).
   PubMedGoogle Scholar
• Giannoudis PV, Tzioupis C. Clinical applications of BMP-7: the UK perspective. Injury36(Suppl. 3), S47–S50 (2005).
   PubMed Web of Science ®Google Scholar
• Giltaij L, Shimmin A, Friedlaender G. Osteogenic protein-1 (OP-1) in the repair of bone defects and fractures of long bones: clinical experience.In: Bone morphogenetic proteins: from laboratory to clinical practice. Vukicevic S, Sampath K (Eds). Birkhauser, MA, USA, 193–206 (2002).
   Google Scholar
• Jones AL. Recombinant human bone morphogenic protein-2 in fracture care. J. Orthop. Trauma19(10 Suppl.), S23–S25 (2005).
   PubMedGoogle Scholar
• McQueen M, Hajducka C, Court-Brown C. A comparison of rhBMP-7 (Ossigraft) and autogenous graft for treatment of metaphyseal defects after osteotomy of the distal radius. In: Annual Meeting of the Orthopedic Trauma Association. Salt Lake City, UT, USA (2003).
   Google Scholar
• Schemitsch E, Waddell J, Wild L. The treatment of long bone nonunion with rhBMP: results of a prospective pilot study. Presented at: The Annual Meeting of the American Academy of Orthopedic Surgeons. San Francisco, CA (2004).
   Google Scholar
• McKee M, Schemitsch E, Waddell J et al. The effect of human recombinant bone morphogenic protein (rhBMP-7) on the healing of open tibial shaft fractures: results of a multi-center, prospective, randomized clinical trial. In: Annual Meeting of the Orthopedic Trauma Association. Toronto, Ontario, Canada (2002).
   Google Scholar
• Swiontkowski MF, Aro HT, Donell S et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J. Bone Joint Surg.88(6), 1258–1265 (2006).
   PubMed Web of Science ®Google Scholar
• Einhorn TA, Majeska RJ, Mohaideen A et al. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J. Bone Joint Surg.85A(8), 1425–1435 (2003).
   Web of Science ®Google Scholar
• Edwards RB, 3rd, Seeherman HJ, Bogdanske JJ et al. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J. Bone Joint Surg.86A(7), 1425–1438 (2004).
   Google Scholar
• Lieberman JR, Daluiski A, Stevenson S et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg.81(7), 905–917 (1999).
   PubMed Web of Science ®Google Scholar
• Abe N, Lee YP, Sato M et al. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem. Biophys. Res. Commun.297(3), 523–527 (2002).
   PubMed Web of Science ®Google Scholar
• Riedel GE, Valentin-Opran A. Clinical evaluation of rhBMP-2/ACS in orthopedic trauma: a progress report. Orthopedics22(7), 663–665 (1999).
   PubMed Web of Science ®Google Scholar